Devyser Diagnostics Management
Management criteria checks 3/4
Devyser Diagnostics' CEO is Fredrik Alpsten, appointed in Sep 2020, has a tenure of 4.33 years. total yearly compensation is SEK5.00M, comprised of 58% salary and 42% bonuses, including company stock and options. directly owns 1.23% of the company’s shares, worth SEK24.15M. The average tenure of the management team and the board of directors is 2.5 years and 4 years respectively.
Key information
Fredrik Alpsten
Chief executive officer
SEK 5.0m
Total compensation
| CEO salary percentage | 58.0% |
| CEO tenure | 4.3yrs |
| CEO ownership | 1.2% |
| Management average tenure | 2.5yrs |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
Analysts Just Made A Substantial Upgrade To Their Devyser Diagnostics AB (publ) (STO:DVYSR) Forecasts
Jun 14
Devyser Diagnostics AB (publ) (STO:DVYSR) Stock Rockets 27% But Many Are Still Ignoring The Company
Mar 20Devyser Diagnostics AB (publ) (STO:DVYSR) Just Reported And Analysts Have Been Cutting Their Estimates
Feb 23Devyser Diagnostics (STO:DVYSR) Is In A Strong Position To Grow Its Business
Feb 22Devyser Diagnostics AB (publ) (STO:DVYSR) Stock Rockets 28% But Many Are Still Ignoring The Company
Dec 09These Analysts Just Made An Incredible Downgrade To Their Devyser Diagnostics AB (publ) (STO:DVYSR) EPS Forecasts
Aug 30Devyser Diagnostics AB (publ) (STO:DVYSR) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -SEK 71m |
| Jun 30 2024 | n/a | n/a | -SEK 54m |
| Mar 31 2024 | n/a | n/a | -SEK 46m |
| Dec 31 2023 | SEK 5m | SEK 3m | -SEK 54m |
| Sep 30 2023 | n/a | n/a | -SEK 57m |
| Jun 30 2023 | n/a | n/a | -SEK 60m |
| Mar 31 2023 | n/a | n/a | -SEK 60m |
| Dec 31 2022 | SEK 4m | SEK 3m | -SEK 46m |
| Sep 30 2022 | n/a | n/a | -SEK 40m |
| Jun 30 2022 | n/a | n/a | -SEK 35m |
| Mar 31 2022 | n/a | n/a | -SEK 27m |
| Dec 31 2021 | SEK 3m | SEK 2m | -SEK 21m |
| Dec 31 2020 | SEK 2m | SEK 519k | -SEK 11m |
Compensation vs Market: Fredrik's total compensation ($USD445.91K) is about average for companies of similar size in the Swedish market ($USD452.46K).
Compensation vs Earnings: Fredrik's compensation has increased whilst the company is unprofitable.
CEO
Fredrik Alpsten (58 yo)
4.3yrs
Tenure
SEK 5,000,000
Compensation
Mr. Fredrik Alpsten is Chief Executive Officer at Devyser Diagnostics AB (publ) since September 01, 2020. He served as Director of Binero Group AB (publ). Mr. Alpsten served as Executive Officer at IRRAS A...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 4.3yrs | SEK 5.00m | 1.23% SEK 24.2m | |
| Chief Financial Officer | 4yrs | no data | no data | |
| Chief Scientific Officer | 2yrs | no data | no data | |
| Chief Human Resource Officer | 2.3yrs | no data | no data | |
| Chief Commercial Officer | 2.6yrs | no data | no data | |
| VP & GM of Devyser US | 2.2yrs | no data | no data |
2.5yrs
Average Tenure
45yo
Average Age
Experienced Management: DVYSR's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director | 9yrs | SEK 200.00k | no data | |
| Independent Director | 3.3yrs | SEK 200.00k | 0.015% SEK 290.3k | |
| Chairman | 15yrs | SEK 300.00k | 24.11% SEK 471.7m | |
| Independent Director | 4yrs | SEK 200.00k | 0.21% SEK 4.0m | |
| Independent Director | less than a year | no data | no data |
4.0yrs
Average Tenure
57yo
Average Age
Experienced Board: DVYSR's board of directors are considered experienced (4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/13 13:32 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Devyser Diagnostics AB (publ) is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Erik Hultgård | Carnegie Investment Bank AB |
| Ludvig Lundgren | Nordea Markets |
| Filip Wiberg | Pareto Securities |